BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35032366)

  • 1. Acute myeloid leukemia due to germline CEBPA mutation in a Syrian family.
    Wafa A; Ali B; Moassass F; Kheder M; Aljapawe A; Al-Halabi B; Mrasek K; Liehr T; Al-Achkar W
    Mol Genet Genomic Med; 2022 Feb; 10(2):e1854. PubMed ID: 35032366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and management of germline CEBPA-mutated carriers.
    Pan L; Li Y; Gao H; Lai X; Cai Y; Chen Z; Li X; Wang SY
    Leuk Res; 2024 Mar; 138():107453. PubMed ID: 38442594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia.
    Pabst T; Eyholzer M; Haefliger S; Schardt J; Mueller BU
    J Clin Oncol; 2008 Nov; 26(31):5088-93. PubMed ID: 18768433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation and clinical analysis of a family with germline CEBPA mutations in acute myeloid leukemia].
    Zhang JP; Lin D; Wang SC; Li Y; Chen YM; Wang Y; Wei H; Mi YC; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2020 Dec; 41(12):1008-1012. PubMed ID: 33445848
    [No Abstract]   [Full Text] [Related]  

  • 5. Germline CEBPA mutation in familial acute myeloid leukemia.
    Boada M; Catalán AI; Ottati C; Bentancour F; Lens D; Guillermo C; Grille S
    Hematol Rep; 2021 Sep; 13(3):9114. PubMed ID: 34733449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features.
    Szankasi P; Ho AK; Bahler DW; Efimova O; Kelley TW
    Leuk Res; 2011 Feb; 35(2):200-7. PubMed ID: 20970189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial CEBPA-mutated acute myeloid leukemia.
    Tawana K; Rio-Machin A; Preudhomme C; Fitzgibbon J
    Semin Hematol; 2017 Apr; 54(2):87-93. PubMed ID: 28637622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow up of a large family.
    Pathak A; Seipel K; Pemov A; Dewan R; Brown C; Ravichandran S; Luke BT; Malasky M; Suman S; Yeager M; ; ; Gatti RA; Caporaso NE; Mulvihill JJ; Goldin LR; Pabst T; McMaster ML; Stewart DR
    Haematologica; 2016 Jul; 101(7):846-52. PubMed ID: 26721895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory evaluation and prognostication among adults and children with CEBPA-mutant acute myeloid leukemia.
    Mendoza H; Podoltsev NA; Siddon AJ
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1():86-95. PubMed ID: 34288448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary acute myeloid leukemia associated with C-terminal CEBPA germline variants.
    Harrigan AM; Trottier AM
    Fam Cancer; 2023 Jul; 22(3):331-339. PubMed ID: 36879149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations.
    Yuan J; He R; Alkhateeb HB
    Curr Hematol Malig Rep; 2023 Oct; 18(5):121-129. PubMed ID: 37261703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CEBPA gene mutation analysis in acute myeloid leukemia].
    Han C; Lin D; Ai XF; Wang F; Sun HY; Wang M; Mi YC; Wang JX; Ru K
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):566-71. PubMed ID: 23906447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease evolution and outcomes in familial AML with germline CEBPA mutations.
    Tawana K; Wang J; Renneville A; Bödör C; Hills R; Loveday C; Savic A; Van Delft FW; Treleaven J; Georgiades P; Uglow E; Asou N; Uike N; Debeljak M; Jazbec J; Ancliff P; Gale R; Thomas X; Mialou V; Döhner K; Bullinger L; Mueller B; Pabst T; Stelljes M; Schlegelberger B; Wozniak E; Iqbal S; Okosun J; Araf S; Frank AK; Lauridsen FB; Porse B; Nerlov C; Owen C; Dokal I; Gribben J; Smith M; Preudhomme C; Chelala C; Cavenagh J; Fitzgibbon J
    Blood; 2015 Sep; 126(10):1214-23. PubMed ID: 26162409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of CEBPA mutation in acute myeloid leukemia].
    Zhang Y; Zhang SJ; Qiu HX; Qiao C; Sun HM; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):859-62. PubMed ID: 20723288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEBPA gene mutations in Egyptian acute myeloid leukemia patients: impact on prognosis.
    Awad MM; Aladle DA; Abousamra NK; Elghannam DM; Fawzy IM
    Hematology; 2013 Mar; 18(2):61-8. PubMed ID: 22990006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA).
    Preudhomme C; Sagot C; Boissel N; Cayuela JM; Tigaud I; de Botton S; Thomas X; Raffoux E; Lamandin C; Castaigne S; Fenaux P; Dombret H;
    Blood; 2002 Oct; 100(8):2717-23. PubMed ID: 12351377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2.
    Snaddon J; Smith ML; Neat M; Cambal-Parrales M; Dixon-McIver A; Arch R; Amess JA; Rohatiner AZ; Lister TA; Fitzgibbon J
    Genes Chromosomes Cancer; 2003 May; 37(1):72-8. PubMed ID: 12661007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular evaluation of CEBPA gene mutation in normal karyotype acute myeloid leukemia: a comparison of two methods and report of novel CEBPA mutations from Indian acute myeloid leukemia patients.
    Ahmad F; Rajput S; Mandava S; Das BR
    Genet Test Mol Biomarkers; 2012 Jul; 16(7):707-15. PubMed ID: 22731647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic heterogeneity of cytogenetically normal AML with mutations of
    Konstandin NP; Pastore F; Herold T; Dufour A; Rothenberg-Thurley M; Hinrichsen T; Ksienzyk B; Tschuri S; Schneider S; Hoster E; Berdel WE; Woermann BJ; Sauerland MC; Braess J; Bohlander SK; Klein HG; Hiddemann W; Metzeler KH; Spiekermann K
    Blood Adv; 2018 Oct; 2(20):2724-2731. PubMed ID: 30337300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia.
    Hollink IH; van den Heuvel-Eibrink MM; Arentsen-Peters ST; Zimmermann M; Peeters JK; Valk PJ; Balgobind BV; Sonneveld E; Kaspers GJ; de Bont ES; Trka J; Baruchel A; Creutzig U; Pieters R; Reinhardt D; Zwaan CM
    Haematologica; 2011 Mar; 96(3):384-92. PubMed ID: 21134981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.